Olaparib and pancreatic cancer: A challenging Lesson

被引：1
|
作者：
Louvet, Christophe [1 ]
Samalin, Emmanuelle [2 ]
Michel, Pierre [3 ]
机构：
[1] Inst Mutualiste Montsouris, Dept Med Oncol, F-75014 Paris, France
[2] Univ Montpellier, Inst Canc Montpellier Val Aurelle, Unite Oncol Gigest, Grp Digestif Unicanc, F-34298 Montpellier 5, France
[3] Normandie Univ, Hop Univ Rouen, Serv Hepatogastroenterol, UNIROUEN,Inserm 1245,IRON Grp,FFCD, F-76000 Rouen, France
来源：
BULLETIN DU CANCER | 2019年 / 106卷 / 09期
关键词：
D O I：
10.1016/j.bulcan.2019.07.002
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：715 / 716
页数：2
相关论文
共 50 条
  • [1] OLAPARIB APPROVED FOR METASTATIC PANCREATIC CANCER
    Aschenbrenner, Diane S.
    AMERICAN JOURNAL OF NURSING, 2020, 120 (04) : 22 - 23
  • [2] Maintenance Olaparib for Metastatic Pancreatic Cancer
    Puccini, Alberto
    Bregni, Giacomo
    Sciallero, Stefania
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (15): : 1491 - 1492
  • [3] An evaluation of olaparib for the treatment of pancreatic cancer
    Vaishampayan, Ulka N.
    EXPERT OPINION ON PHARMACOTHERAPY, 2021, 22 (04) : 521 - 526
  • [4] Maintenance Olaparib for Metastatic Pancreatic Cancer Reply
    Golan, Talia
    Locker, Gershon Y.
    Kindler, Hedy L.
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (15): : 1492 - 1493
  • [5] Olaparib for BRCA-mutant pancreatic cancer
    Baker, Holly
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2019, 4 (08): : 584 - 584
  • [6] Splenosis and Pancreatic Cancer: A Challenging Diagnosis
    Guimaraes, Andreia
    Alexandrino, Henrique
    Velez, Ana
    Tralhao, Jose Guilherme
    MEDICINE, 2020, 99 (23)
  • [7] A new targeted treatment for patients with a germlineBRCAmutation: olaparib in pancreatic cancer
    Verdaguer, Helena
    Acosta, Daniel
    Macarulla, Teresa
    FUTURE ONCOLOGY, 2020, 16 (33) : 2691 - 2700
  • [8] A Challenging Diagnostic Puzzle of Pancreatic Mass: A Pancreatic Cancer Mimic
    Nadeem, Mahum
    Mareth, Karl
    Kamal, Maria
    Haider, Maryam
    Maple, John
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S1436 - S1437
  • [9] Pancreatic Cancer: Proteomic Approaches to a Challenging Disease
    Tonack, Sarah
    Aspinall-O'Dea, Mark
    Neoptolemos, John P.
    Costello, Eithne
    PANCREATOLOGY, 2009, 9 (05) : 567 - 576
  • [10] New drug approval: Olaparib - pancreatic cancer with BRCA germline mutation
    Hilmi, Marc
    Neuzillet, Cindy
    BULLETIN DU CANCER, 2020, 107 (10) : 961 - 962
12345